Qiagen

About:

QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions.

Twitter/X: qiagen

Top Investors: U.S. Department of Defense, U.S. Department of Health & Human Services

Description:

QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics.QIAGEN offers its sample and assay consumable products in kit form.

Total Funding Amount:

$4M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Venlo, Limburg, The Netherlands

Founded Date:

1986-01-01

Founders:

Metin Colpan

Number of Employees:

1001-5000

Last Funding Date:

2021-10-22

IPO Status:

Public

Industries: